McKesson Corporation dba McKesson Drug Company: Drug Recall
Recall #D-0630-2021 · 05/26/2021
Class III: Low Risk
Recall Details
- Recall Number
- D-0630-2021
- Classification
- Class III
- Product Type
- Drug
- Recalling Firm
- McKesson Corporation dba McKesson Drug Company
- Status
- Terminated
- Date Initiated
- 05/26/2021
- Location
- Memphis, TN, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 210 cartons
Reason for Recall
Labeling; Wrong Barcode; error in the machine-readable barcode which could result in some units being read as Naproxen Tablets 500 mg. Product is labeled correctly as Levetiracetam
Product Description
Levetiracetam Tablets USP, 250 mg UD 100 Tablets (10x10) boxes, Rx Only, Distributed By: McKesson Corporation 4971 Southridge Blvd., Suite 101 Memphis, TN 38141 Manufactured by: Aurobindo Pharma Limited Hyderabad-500 090, India NDC 63739-795-10
Distribution Pattern
Nationwide in the US
Other Recalls by McKesson Corporation dba McKesson Drug Company
- Class II: Risk 04/21/2022
- Class II: Risk 04/21/2022
- Class II: Risk 04/21/2022
- Class II: Risk 04/21/2022
- Class II: Risk 04/21/2022
View all recalls by McKesson Corporation dba McKesson Drug Company →
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.